Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 11, 2021, after the close
10-Q filed Aug 11, 2021, 42 days after period end · 0001564590-21-043488
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $0.00 | $15.00M | — | $1.33M |
| Net Income | -$1.54M | -$5.28M | -$5.68M | -$5.99M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.60 |
| $0.23 |
| -$0.14 |
| -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.